Salarius Pharmaceuticals ...

NASDAQ: SLRX · Real-Time Price · USD
5.76
0.14 (2.49%)
At close: Aug 26, 2025, 3:55 PM
5.56
-1.07%
Pre-market: Aug 26, 2025, 08:50 AM EDT

Salarius Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a 1.84M
Cost of Revenue
4.42K 10.05K 6.68K 19.18K
Gross Profit
-4.42K -10.05K -6.68K 1.82M
Operating Income
-5.73M -12.89M -22.98M -12.81M
Interest Income
158.54K 352.25K 218.73 n/a
Pretax Income
-5.58M -12.54M -31.61M -12.77M
Net Income
-5.58M -12.54M -31.37M -12.77M
Selling & General & Admin
4.96M 5.72K 7.14M 6.1M
Research & Development
770.03K 7.17K 15.84M 8.55M
Other Expenses
n/a 12.88M -231 n/a
Operating Expenses
5.73M 12.89M 22.98M 14.65M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-5.73M 22.95K 22.98M 14.65M
Income Tax Expense
n/a -12.53M n/a n/a
Shares Outstanding (Basic)
64.47K 218.73K 142.34K 13.8K
Shares Outstanding (Diluted)
64.47K 218.73K 142.34K 13.86K
EPS (Basic)
-86.85 -0.06 -221.55 -930
EPS (Diluted)
-86.85 -0.06 -221.55 -930
EBITDA
-5.57M -2.84K -31.6M -12.79M
EBIT
-5.58M -12.89K -31.61M -12.81M
Depreciation & Amortization
4.42K 10.05K 6.68K 19.18K